Status:
COMPLETED
Enhancing Donated After Cardiac Death (DCD) Utilization With Thrombolytic Therapy
Lead Sponsor:
The Cleveland Clinic
Collaborating Sponsors:
Health Resources and Services Administration (HRSA)
Conditions:
Liver Transplantation
Kidney Transplantation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
We hypothesize that delayed graft function and ITBS events may be related to small blood clots (microthrombi) that collect in the kidneys and liver after cardiac death. Treatment of the DCD organs wit...
Detailed Description
The waiting list for kidney and liver transplantation continues to increase in the United States, and therefore the need grows for additional donor organs. Utilization of organs donated after cardiac ...
Eligibility Criteria
Inclusion
- Adults aged 18 years and older
- Subjects willing/able to provide written consent
- Subjects willing/able to comply with study requirements
- Subjects who will receive a solitary organ transplant
Exclusion
- Subjects requiring multi-organ transplants
- Women who are pregnant
- Subjects with current severe systemic infection
- Subjects with an active infection
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2018
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT01197573
Start Date
April 1 2010
End Date
May 1 2018
Last Update
August 28 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals / Case medical Center
Cleveland, Ohio, United States, 44106
2
Cleveland Clinic
Cleveland, Ohio, United States, 44195